These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20927317)

  • 1. A critical role of c-Cbl-interacting protein of 85 kDa in the development and progression of head and neck squamous cell carcinomas through the ras-ERK pathway.
    Wakasaki T; Masuda M; Niiro H; Jabbarzadeh-Tabrizi S; Noda K; Taniyama T; Komune S; Akashi K
    Neoplasia; 2010 Oct; 12(10):789-96. PubMed ID: 20927317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of GRB2-associated binder 1 in epidermal growth factor receptor-induced signaling in head and neck squamous cell carcinoma.
    Hoeben A; Martin D; Clement PM; Cools J; Gutkind JS
    Int J Cancer; 2013 Mar; 132(5):1042-50. PubMed ID: 22865653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Van Waes C; Chen Z
    Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual blockade of EGFR and c-Met abrogates redundant signaling and proliferation in head and neck carcinoma cells.
    Xu H; Stabile LP; Gubish CT; Gooding WE; Grandis JR; Siegfried JM
    Clin Cancer Res; 2011 Jul; 17(13):4425-38. PubMed ID: 21622718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CIN85 is required for Cbl-mediated regulation of antigen receptor signaling in human B cells.
    Niiro H; Jabbarzadeh-Tabrizi S; Kikushige Y; Shima T; Noda K; Ota S; Tsuzuki H; Inoue Y; Arinobu Y; Iwasaki H; Shimoda S; Baba E; Tsukamoto H; Horiuchi T; Taniyama T; Akashi K
    Blood; 2012 Mar; 119(10):2263-73. PubMed ID: 22262777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of ten newly-derived human head and neck squamous carcinoma cell lines with special reference to c-erbB proto-oncogene expression.
    O-Charoenrat P; Rhys-Evans P; Eccles S
    Anticancer Res; 2001; 21(3B):1953-63. PubMed ID: 11497283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion.
    Rao VH; Kandel A; Lynch D; Pena Z; Marwaha N; Deng C; Watson P; Hansen LA
    Oncogene; 2012 Jun; 31(23):2888-98. PubMed ID: 21986939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.
    Hu Y; Mintz A; Shah SR; Quinones-Hinojosa A; Hsu W
    Carcinogenesis; 2014 Jul; 35(7):1491-9. PubMed ID: 24445144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SHP2 promotes laryngeal cancer growth through the Ras/Raf/Mek/Erk pathway and serves as a prognostic indicator for laryngeal cancer.
    Gu J; Han T; Ma RH; Zhu YL; Jia YN; Du JJ; Chen Y; Jiang XJ; Xie XD; Guo X
    Int J Oncol; 2014 Feb; 44(2):481-90. PubMed ID: 24297342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells.
    Bourguignon LY; Gilad E; Brightman A; Diedrich F; Singleton P
    J Biol Chem; 2006 May; 281(20):14026-40. PubMed ID: 16565089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor.
    Lui VW; Thomas SM; Zhang Q; Wentzel AL; Siegfried JM; Li JY; Grandis JR
    Oncogene; 2003 Sep; 22(40):6183-93. PubMed ID: 13679857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.
    Piiper A; Elez R; You SJ; Kronenberger B; Loitsch S; Roche S; Zeuzem S
    J Biol Chem; 2003 Feb; 278(9):7065-72. PubMed ID: 12496267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEK-ERK (Raf/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase) pathway.
    Kim EJ; Juhnn YS
    J Biol Chem; 2015 Apr; 290(15):9604-13. PubMed ID: 25713071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
    Wen-Sheng W
    Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting ERBB receptors shifts their partners and triggers persistent ERK signaling through a novel ERBB/EFNB1 complex.
    Vermeer PD; Colbert PL; Wieking BG; Vermeer DW; Lee JH
    Cancer Res; 2013 Sep; 73(18):5787-97. PubMed ID: 23811940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of epidermal growth factor receptor mediates dasatinib-induced apoptosis in head and neck squamous cell carcinoma cells.
    Lin YC; Wu MH; Wei TT; Chuang SH; Chen KF; Cheng AL; Chen CC
    Neoplasia; 2012 Jun; 14(6):463-75. PubMed ID: 22787428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo.
    Bruzzese F; Di Gennaro E; Avallone A; Pepe S; Arra C; Caraglia M; Tagliaferri P; Budillon A
    Clin Cancer Res; 2006 Jan; 12(2):617-25. PubMed ID: 16428508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Matsushita R; Mataki H; Mizuno K; Okamoto Y; Seki N
    J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Role of DUSP6 in the EGFR-mediated Progression of Head and Neck Squamous Cell Carcinoma.
    Tai CH; Wang CC; Shih YC; Chen YJ; Chen BK; Chen LC
    Anticancer Res; 2024 Jun; 44(6):2545-2554. PubMed ID: 38821599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 20-HETE activates the Raf/MEK/ERK pathway in renal epithelial cells through an EGFR- and c-Src-dependent mechanism.
    Akbulut T; Regner KR; Roman RJ; Avner ED; Falck JR; Park F
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F662-70. PubMed ID: 19570883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.